InMode
21084 Bake Parkway
Suite 106
Lake Forest
California
92630
United States
Tel: 855-411-2639
Website: http://inmodemd.com/
Email: info@inmodemd.com
About InMode
InMode's technology advancements is the new gold standard for aesthetic medicine. Two decades ago our R&D team were critical in developing state-of-the-art light, laser, and radiofrequency devices, thereby launching and shaping the industry. Our technology continues that legacy in providing superior satisfaction for both the patient and the practice. InMode has revolutionary non-invasive options for fractional skin treatment and contraction (Fractora), skin tightening (Forma&Plus), ultra-fast diode hair removal (Diolaze), peak power photofacial for skin pigmentation and vascular lesions (Lumecca), and cellulite reduction/body contouring (BodyFX).LEADERSHIP:
CEO: Erik Dowell
PRODUCTS:
All Products
FOLLOW InMode:
Tweets by Inmode
52 articles with InMode
-
InMode Reports First Quarter 2022 Financial Results
5/2/2022
InMode Ltd. announced its consolidated financial results for the first quarter ended March 31, 2022.
-
InMode to Participate in Investor Conferences in March 2022
3/2/2022
InMode Ltd., a leading global provider of innovative medical technologies, announced that management will participate in the following investor conferences in March.
-
InMode Reports Record Fourth Quarter and Full Year 2021 Financial Results:
2/10/2022
InMode Ltd. today announced its consolidated financial results for the fourth quarter and full year ended Dec. 31, 2021.
-
InMode Expects Record Fourth Quarter & Full Year 2021 Financial Results, Q4 Revenue Between $109.5M-$110M
1/12/2022
Conference call to be held on February 10 at 8:30 a.m. Eastern Time to release its financial results for the fourth quarter and full year 2021 before the Nasdaq market opens on Thursday, February 10, 2022.
-
InMode to Present at the 24th Needham Virtual Growth Conference
1/3/2022
InMode Ltd. today announced that Moshe Mizrahy, Chairman and Chief Executive Officer and Yair Malca, Chief Financial Officer, will present at the 24th Annual Needham Virtual Growth Conference on January 12, 2022, at 9:15am EST.
-
InMode to Participate in Upcoming Virtual Investor Conferences in November
11/4/2021
InMode Ltd. today announced that Moshe Mizrahy , Chief Executive Officer and Yair Malca , Chief Financial Officer will participate in the following upcoming virtual investor conferences:
-
InMode Reports Record Third Quarter 2021 Financial Results: Quarterly Revenue of $94.2M, 58% Year-Over-Year Growth; GAAP Net Income of $44.7M, 87% increase compared to Q3 2020
10/26/2021
InMode Ltd. today announced its consolidated financial results for the third quarter ended September 30, 2021 .
-
InMode Ltd. Announces 2-for-1 Share Split
9/17/2021
InMode Ltd. today announced a two-for-one (2:1) share split of the Company's ordinary shares, with a record date of September 27, 2021 (the "Record Date").
-
InMode to Participate in Upcoming Virtual Conferences in September
9/9/2021
InMode Ltd. today announced that management will participate in the following upcoming conferences: Baird Global Healthcare Conference
-
InMode to Participate in Upcoming August Conferences
8/3/2021
InMode Ltd. today announced that management will participate in the following upcoming conferences: Canaccord Genuity's 41st Annual Growth Virtual Conference Yair Malca , Chief Financial Officer, will participate in a virtual fireside chat on August 12 at 11:30 am. ET
-
InMode Reports Record Second Quarter 2021 Financial Results: Quarterly Revenues of $87.3 Million Represent 184% Year Over Year Growth
7/28/2021
InMode Ltd., a leading global provider of innovative medical technologies, announced its consolidated financial results for the second quarter ended June 30, 2021.
-
InMode Expects Record Second Quarter 2021 Revenue Between $86.5M-$87.0M, Increasing Full Year 2021 Revenue Guidance to $305-$315M
7/12/2021
InMode Ltd., a leading global provider of innovative medical technologies, announced that it expects to release its financial results for the second quarter of 2021 before the Nasdaq market opens on Wednesday, July 28, 2021.
-
InMode to Present at the UBS Global Healthcare Virtual Conference
5/13/2021
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that management will participate in a fireside chat at the UBS Global Healthcare Virtual Conference on Wednesday, May 26.
-
InMode Reports First Quarter 2021 Financial Results: Quarterly Revenues of $65.5 Million Represent 62% Year over Year Growth. GAAP Earnings per Share of $0.63, 320% Year over Year Growth
5/5/2021
InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced consolidated financial results for its first quarter ended March 31, 2021 .
-
InMode Expects First Quarter 2021 Revenue Between $65.0-$65.4M, Non-GAAP Earnings per Diluted Share Between $0.65-$0.67
4/12/2021
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the first quarter 2021 before the Nasdaq market opens on Wednesday, May 5, 2021 .
-
InMode Files ITC Complaint Against ILOODA and its U.S. Distributor, Cutera
3/16/2021
InMode Ltd., a leading global provider of innovative medical technologies, has filed a complaint with the United States International Trade Commission alleging ILOODA's SecretRF fractional radio frequency microneedling system, distributed in the United States by Cutera, Inc., infringes U.S. Patent No. 10,799,285.
-
InMode Reports Record Fourth Quarter and Full Year 2020 Financial Results; Quarterly Revenues of $75.2 Million Represent 60% Year over Year Growth
2/10/2021
InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced consolidated financial results for its fourth quarter and full year ended December 31, 2020 .
-
InMode Expects Record Fourth Quarter and Full Year 2020 Results, Fourth Quarter Revenue Between $74.5-$75M, Non-GAAP Earnings per Diluted Share Between $0.91-$0.93; Announces 2021 Full Year Revenue Guidance of $250- $260M
1/12/2021
InMode Ltd., a leading global provider of innovative medical technologies, announced that it expects to release its financial results for the fourth quarter and full year 2020 before the Nasdaq market opens on Wednesday, February 10, 2021.
-
InMode to Participate at the 2021 ICR Conference
1/11/2021
- InMode Ltd. (Nasdaq: INMD ), a leading global provider of innovative medical technologies, today announced its participation in the 2021 ICR Conference, which is being held virtually January 11-14, 2021 .
-
InMode Announces Corporate Social Responsibility Strategy
1/6/2021
InMode Ltd., a leading global provider of innovative medical technologies, announced it will present a corporate social responsibility strategy in its annual 20-F filing, to report the Company's sustainable practices as it continues to expand into new communities and markets.